Skip to content
English

European Union Projects

Labplus - Telemedicine technology supporting diagnostics

based on automatic analysis of laboratory test results, taking into account the medical questionnaire

The project is being implemented in 2024-2026 as part of the “Innovative Enterprises” Measure of the “European Funds for Entrepreneurial Lower Silesia” Priority of the European Funds for Lower Silesia 2021-2027 Program.

The main objective of the project is to develop innovative telemedicine technology that improves the diagnostic and therapeutic process. Using advanced algorithms, the system will provide patients and medical staff with immediate support in interpreting a wide range of laboratory test results in combination with a dynamic medical questionnaire.

  • 7 116 986.36 PLN

    project value

  • 4 974 346.17 PLN

    European Union funds contribution

Completed

Labplus – a globally innovative medical diagnostics technology

The project “Labplus – a globally innovative medical diagnostics technology” was implemented in years 2019-2024 under Sub-measure 1.1.1 “Industrial research and development work implemented by enterprises” of the Smart Growth Operational Programme 2014-2020.  

The main objective of the project was to develop a globally unique medical diagnostics technology that enables the proposal of a set of laboratory tests without the involvement of a physician, and the remote suggestion of pathology causes.

  • 5 995 983.49 PLN

    project value

  • 4 746 548.44 PLN

    European Union funds contribution

Information on project funding (available in Polish)

Promotional Video

Marketing materials, including a promotional film produced as part of the project “Labplus – a globally innovative medical diagnostics technology” and co-financed by the European Union, are available in our archive. If you require access, please contact us.

Labplus Healthcare

The project “Labplus Healthcare” was implemented in years 2021-2022 and co-financed by the European Union under the Smart Growth Operational Programme 2014-2020 (Action 1.3: R&D activity financed with capital funds participation, Sub-measure 1.3.1: Support for R&D projects at the ‘pre-seed’ stage by proof of concept funds – BRIdge Alfa).

The aim was to develop and implement a technological solution for medical platforms and medical portals that enables automatic forecasting based on laboratory test results and a personalized online medical questionnaire.  

  • 1 100 000.00 PLN

    project value

  • 800 000.00 PLN

    European Union contribution